ArticleJournal for immunotherapy of cancer2016

Pancreatic cancer stem cells in patient pancreatic xenografts are sensitive to drozitumab, an agonistic antibody against DR5.

Jason W-L Eng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.